1653 related articles for article (PubMed ID: 18661411)
41. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
Namba Y; Oka K; Moriyama T; Ichimaru N; Kyo M; Kokado Y; Ito T; Imai E; Aozasa K; Okuyama A; Takahara S
Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
[TBL] [Abstract][Full Text] [Related]
42. A case of living-related renal transplant from the donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
[TBL] [Abstract][Full Text] [Related]
43. Post-reperfusion rapidly progressive glomerulonephritis in post-transplant IgA nephropathy.
Tovbin D; Shnaider A; Kachko L; Basok A; Vorobiov M; Rogachev B; Abramov D; Zlotnik M
J Nephrol; 2004; 17(1):130-3. PubMed ID: 15151270
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors in immunoglobulin-A nephropathy.
Muthukumar T; Fernando ME; Jayakumar M
J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
[TBL] [Abstract][Full Text] [Related]
45. IgA nephropathy in teaching hospitals of Dhaka.
Sharmin F; Khan BR; Rahman M; Rashid HU; Islam B; Kamal M; Barua AR; Chowdhury MA; Mohsin AU; Ahmed S
Bangladesh Med Res Counc Bull; 1997 Apr; 23(1):25-9. PubMed ID: 9363674
[TBL] [Abstract][Full Text] [Related]
46. Two cases of ANCA-associated vasculitis in post-transplant kidney: relapse and de novo.
Tabata H; Honda K; Moriyama T; Itabashi M; Taneda S; Takei T; Tanabe K; Teraoka S; Yamaguchi Y; Oda H; Nitta K
Clin Transplant; 2009 Aug; 23 Suppl 20():49-53. PubMed ID: 19594597
[TBL] [Abstract][Full Text] [Related]
47. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
[TBL] [Abstract][Full Text] [Related]
48. Is kidney graft biopsy indicated in recipients with newly developed, microscopic hematuria?
Kim YS; Jeong HJ; Kim MS; Kim SI; Han DS; Park K
Clin Transplant; 1998 Apr; 12(2):104-8. PubMed ID: 9575397
[TBL] [Abstract][Full Text] [Related]
49. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
[TBL] [Abstract][Full Text] [Related]
50. Focal and segmental glomerulosclerosis in renal allograft recipients: a clinico-pathologic study of 37 cases.
Gupta R; Sharma A; Mahanta PJ; Agarwal SK; Dinda AK
Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):8-14. PubMed ID: 23354185
[TBL] [Abstract][Full Text] [Related]
51. A primer on recurrent and de novo glomerulonephritis in renal allografts.
Ivanyi B
Nat Clin Pract Nephrol; 2008 Aug; 4(8):446-57. PubMed ID: 18560395
[TBL] [Abstract][Full Text] [Related]
52. Histological alterations in renal specimens as indicators of prognosis of IgA nephropathy.
Okada H; Suzuki H; Konishi K; Sakaguchi H; Saruta T
Clin Nephrol; 1992 May; 37(5):235-8. PubMed ID: 1606773
[TBL] [Abstract][Full Text] [Related]
53. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
54. Recurrence of IgA nephropathy 17 months after renal transplantation in the allograft transmitted thin basement membrane disease (TBMD) from donor.
Nakagawa Y; Saito K; Nishi S; Bilim V; Tanikawa T; Ueno M; Shimada H; Osawa Y; Arakawa M; Takahashi K
Clin Transplant; 1999; 13 Suppl 1():59-62. PubMed ID: 10751059
[TBL] [Abstract][Full Text] [Related]
55. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
[TBL] [Abstract][Full Text] [Related]
56. Membranous nephropathy: recurrence after kidney transplantation.
Marcen R; Mampaso F; Teruel JL; Rivera ME; Orofino L; Navarro-Antolin J; Ortuño J
Nephrol Dial Transplant; 1996 Jun; 11(6):1129-33. PubMed ID: 8671981
[TBL] [Abstract][Full Text] [Related]
57. Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival.
Cosio FG; Frankel WL; Pelletier RP; Pesavento TE; Henry ML; Ferguson RM
Am J Kidney Dis; 1999 Oct; 34(4):731-8. PubMed ID: 10516356
[TBL] [Abstract][Full Text] [Related]
58. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
Frank K; Zeier M; Gross ML; Waldherr R; Ritz E; Amann K
Nephrol Dial Transplant; 2006 May; 21(5):1365-72. PubMed ID: 16449275
[TBL] [Abstract][Full Text] [Related]
60. Cholesterol crystal embolic disease in renal allografts.
Scolari F; Tardanico R; Pola A; Mazzucchelli C; Maffeis R; Bonardelli S; Maiorca P; Movilli E; Sandrini S
J Nephrol; 2003; 16(1):139-43. PubMed ID: 12649545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
